Companies

New data point to the clinical and economic value of Medtronic’s cardiac resynchronization therapy devices for the treatment of heart failure.

Covidien’s acquisition of Sapheon this summer is looking like a smart move as pivotal clinical study results at 6 months suggest it successfully treats symptomatic varicose veins.

DePuy Synthes Spine is launching a collection of new implants and instruments for the SYNAPSE Platform, which is used for posterior stabilization of the upper spine.

The North American Spine Society (NASS) annual meeting sees DePuy Synthes Spine announcing the introduction of ViviGen™ Cellular Bone Matrix for the repair or reconstruction of musculoskeletal defects.

Stryker’s clever neuro blood-clot removal device has received the Prix Galien USA 2014 Award for Best Medical Technology.

ConMed Corporation has announced the appointment of Curt Hartman as President and Chief Executive Officer, effective immediately.

DePuy Synthes Mitek Sports Med Unveils a New Hybrid Anchor Technology for Arthroscopic Repair of Shoulder and Hip Instability

The biggest trial of a drug-eluting peripheral vascular stent has yielded impressive results out to five years when compared with balloon angioplasty or bare metal stents.

Covidien says the HawkOne™ System strengthens its directional atherectomy platform with a versatile solution for the treatment of peripheral arterial disease.

The spin-off will create a new publicly traded company called SeaSpine, focused on developing, marketing and selling spine hardware and orthobiologics.

First and Only DES with Novel CoreWire Technology Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength

Spectranetics is to acquire Covidien’s Stellarex™ drug coated angioplasty balloon platform in a move that is likely to be part of the plan to meet anti-trust conditions related to next year’s takeover by Medtronic.

Can CRT optimization using SonR heart sensor improve outcome in heart failure patients? A significant study, now fully enrolled, should tell us.

Zimmer Holdings, Inc., is offering us an advance preview of its future executive leadership team and organizational structure of what is to be called Zimmer Biomet.

Integra LifeSciences Holdings Corporation has completed the acquisition of the MicroFrance and Xomed instrument lines from Medtronic.

Abbott is to acquire Topera with its clever diagnostic catheter and mapping software that offers improved outcomes from cardiac ablation for atrial fibrillation.